Endava stock falls 1.31 percent as lawsuit deadline nears

Published on 10/07/2026 at 00:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Endava stock traded at USD 1.8850 on October 6, 2026, while Q3 FY26 revenue reached USD 178.54 million. Nine analysts set a USD 5.36 average target.

DAVA, US29260V1052, Illustration mit AI erstellt.

Endava plc (ISIN US29260V1052) was trading at USD 1.8850 on the NYSE on October 6, 2026 at 3:45 p.m. EDT, down 1.31 percent from the previous close. A pending securities class action and its November 30, 2026 lead plaintiff deadline now frame the stock's immediate risk profile, as GlobeNewswire reported on October 6, 2026.

Lawsuit deadline reaches November 30

The complaint challenges Endava's SEC disclosures and alleges that accounting for certain customer and supplier agreements required further review. Those claims are allegations, not findings by a court, but they add a legal overhang to a company already facing delayed annual reporting.

Endava said on September 21, 2026 that it had appointed Conor McShane as interim chief financial officer after placing Mark Thurston on administrative leave pending an investigation by independent outside counsel, according to Endava. The company also said it intended to publish fiscal fourth quarter and full year 2026 results by November 2, 2026.

Quarterly loss overwhelms revenue

The latest reported interim period was Q3 FY26, ended March 31, 2026. Endava generated USD 178.54 million in revenue, while the earnings line showed a USD 394.44 million loss and a negative 220.93 percent margin, figures displayed by Yahoo Finance.

Endava provides digital engineering, cloud, data, artificial intelligence and managed technology services across industries including payments, banking, healthcare, retail and telecommunications. The company reported 11,225 employees as of March 31, 2026 in its September 21 release, making the accounting review relevant to a broad operating platform rather than a single product line.

Consensus target stays above the price

MarketBeat reported a Reduce consensus from nine brokerages, comprising three sell ratings, five holds and one buy rating. The average 12-month target was USD 5.36, which lies 184.4 percent above the USD 1.8850 reference price, while the consensus remains a forecast rather than a guaranteed outcome.

Market value remains compressed

Endava's market capitalization was USD 99.6 million on October 6, 2026, and the session volume reached 83,724 shares. The USD 1.6000 to USD 9.8800 52-week range places the stock 80.9 percent below its yearly high, leaving the legal investigation, reporting timetable and next results as the central valuation checkpoints.